Roche Holding Aktiengesellschaft operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Roche Holding Aktiengesellschaft with three other
pharmaceutical manufacturers in Europe:
GlaxoSmithKline plc
of UNITED KINGDOM
(2019
sales of £33.75 billion [US$41.77 billion]
of which 52%
was Pharmaceuticals),
Bayer AG
of GERMANY
(43.55 billion Euros [US$47.75 billion]
of which 46%
was CropScience), and
Novartis AG
(48.29 billion Swiss Francs [US$49.99 billion]
of which 78%
was Innovative Medicines).
Sales Analysis.
Roche Holding Aktiengesellschaft reported sales of 61.47 billion Swiss Francs (US$63.63 billion)
for the
year ending
December of 2019.
This
represents
an
increase of 8.1%
versus 2018, when the company's sales were 56.85 billion Swiss Francs.
Sales at Roche Holding Aktiengesellschaft have increased during each of the previous five years
(and since 2014, sales have increased a total of 30%).
Sales of Pharmaceuticals saw an increase
of
10.3% in 2019, from
43.97 billion Swiss Francs to 48.52 billion Swiss Francs.